Skip to main content
. 2023 Feb 27;315(7):1897–1908. doi: 10.1007/s00403-023-02557-x

Table 1.

PXE patient characteristics

In this study cohort Data from the literature
Total (n) 25
Age (years) 48.4 ± 13.87 31.7 [41], 47 ± 15 [42]
Male sex (n) 8 (32%) 32% [8], 36% [42]
Onset (age; years) 20 [14–22.5] 13.54 [43], 21 ± 14 [44]
Duration (years) 20.5 ± 15.8
Smoking (n) 10 (40%) 35% [43], 30% [42]
BMI (kg/cm2) 24.27 (22.93–18.10)
Osteopenia/osteoporosis (n) 6 (24%) 23–46% [42]
Gastrointestinal hemorrhage (n) 1 (4%) 18% [41]
Nephrolithiasis (n) 6 (24%) 39.8% [45]
Skin (n)
 Plaques 15 (60%)
 Redundant skin folds 7 (28%) 93% [41]
 Acneiform lesions 10 (40%)
 Mucosal involvement 10 (40%) 21.4% [32]
 Typical areas 6.2 ± 1.8
 Atypical areas 0 [0–1]
 CA 23.3 ± 16.15
 CD 51.6 ± 22.1
 CS 1436.0 ± 1182.5
 Elastic fiber number/FOV 40.8 ± 27.7
 Elastic fiber length (μ m) 32.3 [25.4–34.9]
Eye (n)
 Peau d’orange 4 (16%) 84.9% [44]
 Angioid streaks 22 (88%) 93.75% [35], 92.5% [44]
 Choroidal neovascularization 10 (40%) 42.5% [35], 50.9% [44]
 Bleeding and/or scarring 2 (8%) 44% [44]
 Macular atrophy 5 (20%) 32% [34]
 Blindness 5 (20%) 10.9% [46]
Vascular (n)
 Weak or absent pulses 7 (28%)
 Intermittent claudication 9 (36%) 42–53% [37]
 Lower limb revascularization 0 (0%)
 ICAH 4 (16%) 8.6% [47]
 Peripheral artery disease 7 (28%) 37–57% [48]
 High blood pressure 4 (16%) 8–25% [37]
 Stroke/TIA 1 (4%) 15% [38]
 Ankle-brachial index 1.1 [0.83–1.15] 0.92 ± 0.19% [48]
Cardiac (n)
 Chest pain/angina/abnormal ECG 5 (20%) 13–15% [38]
 Cardiac attack 0 (0%) 1–5% [38]
Phenodex + score 5.64 ± 1.8
S 2 [1–2.5]
E 2 [7, 36]
G 0 [0–0]
V 1 [0–2]
C 0 [0–0]
R 0 [0–0.5]

Data is expressed as mean ± standard error for normally distributed continuous variables, median [range] for nonparametric distributed continuous variables and number (%) for categorical variables

CA calcification area, CD calcification density, CS total calcification score, ICAH internal carotid artery hypoplasia, TIA transient ischemic attack, ECG electrocardiography